Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4030556 | Ophthalmology | 2007 | 13 Pages |
Abstract
This review found limited level I evidence for any intervention to improve VA in patients with CRVO. Panretinal photocoagulation resulted in regression of neovascularization. Hemodilution may improve vision in some patients, but the data conflict. More robust randomized controlled trials evaluating current treatments for CRVO are needed. The results of ongoing RCTs on intravitreal triamcinolone, anti-vascular endothelial growth factor agents, and chorioretinal anastomosis are awaited with interest.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Quresh MBBS, FRCOphth, Rachel L. BOrthop, Seang Mei MBBS, PhD, Tien Yin FRANZCO, PhD,